CAPR CIK: 1133869

Capricor Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.8
FY22:
4.92
FY23:
−25.6
FY24:
−40.0
FY25:
−69.8
Change from FY21 to FY25
millions USD
FY21:
−1.20
FY22:
−35.1
FY23:
5.11
FY24:
−116
FY25:
97.5
Change from FY21 to FY25
millions USD
FY21:
20.2
FY22:
4.87
FY23:
25.6
FY24:
153
FY25:
249
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.0
FY22:
2.92
FY23:
−26.9
FY24:
−41.2
FY25:
−72.7

All amounts in millions USD Data source:SEC EDGAR